This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Zero based budgeting yields tangible outcomes compared to traditional budgeting, including tighter control and clearer allocation of resources.
22,247 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Magnum Ice Cream’s public split from Unilever has turned Ben & Jerry’s into a governance flashpoint. The brand’s acti...
Broadcom has surged after April began, but the big question remains: is the rally sustainable? This guide breaks down...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
Nvidia’s growth has stunned the market, but a new pledge from Jensen Huang signals a major shift in capital returns. ...
NVIDIA CEO Jensen Huang challenges the AI jobs doomsayers narrative as the company posts blockbuster revenue driven b...
Famed investor Michael Burry reportedly tacks a bearish stance onto Micron Technology, signaling renewed caution for ...
A pivotal move in AI investing just happened: a memory-focused chip stock joined Nasdaq, giving investors a new way t...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Analysts boosted price targets on Three consumer names ahead of earnings, signaling renewed optimism on momentum and ...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...